Top

Published in:

01-03-2016 | Female Urology (K Kobashi, Section Editor)

Underactive Bladder

Authors: Himanshu Aggarwal, Philippe E. Zimmern

Published in: Current Urology Reports | Issue 3/2016

Abstract

Underactive bladder (UAB) is a very common condition leading to disabling lower urinary tract symptoms. There has been an increasing interest in this condition as there is no effective treatment currently available. UAB has been described in many ways, but there is no agreed upon consensus on its terminology. The prevalence of UAB may be underestimated. This review focuses on the terminology, pathophysiology, common causes, its treatment, and future areas of research.

1.•

Miyazato M, Yoshimura N, Chancellor MB. The other bladder syndrome: underactive bladder. Reviews in Urology. 2013;15(1):11–22. (Article describing UAB terminology).

Alexander S, Rowan D. Treatment of patients with hypotonic bladder by radio-implant. Br J Surg. 1972;59(4):302.PubMed

Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. NeurourolUrodyn. 2002;21(2):167–78.

Anderson JB, Grant JB. Postoperative retention of urine: a prospective urodynamic study. BMJ (Clinical research ed). 1991;302(6781):894–6.CrossRef

Kirby RS, Fowler C, Gilpin SA, Holly E, Milroy EJ, Gosling JA, et al. Non-obstructive detrusor failure. A urodynamic, electromyographic, neurohistochemical and autonomic study. Br J Urol. 1983;55(6):652–9.PubMedCrossRef

6.••

van Koeveringe GA, Rademakers KL, Birder LA, Korstanje C, Daneshgari F, Ruggieri MR, et al. Detrusor underactivity: pathophysiological considerations, models and proposals for future research. ICI-RS. Neurourology and Urodynamics 2014. 2013;33(5):591–6. (Review discussing various animal models in detail for UAB research).

Andersson KE. The many faces of impaired bladder emptying. Curr Opin Urol. 2014;24(4):363–9.PubMedCrossRef

Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P. The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up. BJU Int. 2004;93(6):745–50.PubMedCrossRef

Van Koeveringe GA, Rademakers KL. Factors impacting bladder underactivity and clinical implications. Minerva urologica e nefrologica. The Italian J Urology and Nephrology. 2015;67(2):139–48.

10.

Osman NI, Chapple CR, Abrams P, Dmochowski R, Haab F, Nitti V, et al. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. European urology. 2014;65(2):389–98.PubMedCrossRef

11.

Chapple CR, Osman NI, Birder L, van Koeveringe GA, Oelke M, Nitti VW, Drake MJ, Yamaguchi O, Abrams P, Smith PP: The underactive bladder: a new clinical concept? European urology 2015

12.

Resnick NM, Yalla SV. Detrusor hyperactivity with impaired contractile function. An unrecognized but common cause of incontinence in elderly patients. Jama. 1987;257(22):3076–81.PubMedCrossRef

13.

Cucchi A, Quaglini S, Rovereto B. Different evolution of voiding function in underactive bladders with and without detrusor overactivity. J Urol. 2010;183(1):229–33.PubMedCrossRef

14.

Valente S, DuBeau C, Chancellor D, Okonski J, Vereecke A, Doo F, et al. Epidemiology and demographics of the underactive bladder: a cross-sectional survey. Int Urol Nephrol. 2014;46 Suppl 1:S7–10.PubMedCrossRef

15.

Abarbanel J, Marcus EL. Impaired detrusor contractility in community-dwelling elderly presenting with lower urinary tract symptoms. Urology. 2007;69(3):436–40.PubMedCrossRef

16.

Jeong SJ, Kim HJ, Lee YJ, Lee JK, Lee BK, Choo YM, et al. Prevalence and clinical features of detrusor underactivity among elderly with lower urinary tract symptoms: a comparison between men and women. Korean J Urology. 2012;53(5):342–8.CrossRef

17.

Elbadawi A, Yalla SV, Resnick NM. Structural basis of geriatric voiding dysfunction. II. Aging detrusor: normal versus impaired contractility. J Urol. 1993;150(5 Pt 2):1657–67.PubMed

18.

Taylor 3rd JA, Kuchel GA. Detrusor underactivity: clinical features and pathogenesis of an underdiagnosed geriatric condition. J Am Geriatr Soc. 2006;54(12):1920–32.PubMedCrossRef

19.

Smith PP. Aging and the underactive detrusor: a failure of activity or activation? NeurourolUrodyn. 2010;29(3):408–12.

20.

Fry CH, Bayliss M, Young JS, Hussain M. Influence of age and bladder dysfunction on the contractile properties of isolated human detrusor smooth muscle. BJU Int. 2011;108(2 Pt 2):E91–96.PubMedCrossRef

21.

Brierly RD, Hindley RG, McLarty E, Harding DM, Thomas PJ. A prospective controlled quantitative study of ultrastructural changes in the underactive detrusor. J Urol. 2003;169(4):1374–8.PubMedCrossRef

22.

Smith PP, Chalmers DJ, Feinn RS: Does defective volume sensation contribute to detrusor underactivity? Neurourology and urodynamics 2014.

23.

Smith PP, DeAngelis A, Kuchel GA. Detrusor expulsive strength is preserved, but responsiveness to bladder filling and urinary sensitivity is diminished in the aging mouse. Am J Physiol Regul Integr Comp Physiol. 2012;302(5):R577–586.PubMedCentralPubMedCrossRef

24.

Daneshgari F, Liu G, Birder L, Hanna-Mitchell AT, Chacko S. Diabetic bladder dysfunction: current translational knowledge. J Urol. 2009;182(6 Suppl):S18–26.PubMedCentralPubMedCrossRef

25.

Bansal R, Agarwal MM, Modi M, Mandal AK, Singh SK. Urodynamic profile of diabetic patients with lower urinary tract symptoms: association of diabetic cystopathy with autonomic and peripheral neuropathy. Urology. 2011;77(3):699–705.PubMedCrossRef

26.

Kaplan SA, Te AE, Blaivas JG. Urodynamic findings in patients with diabetic cystopathy. J Urol. 1995;153(2):342–4.PubMedCrossRef

27.

Changxiao H, Zhengyong Y, Shibing Y, Caiwen W, Yingchuan H, Wei H, et al. Clinical and urodynamic evaluation of women referred with diabetes mellitus. International Urogynecology J. 2014;25(7):979–83.CrossRef

28.

Wang Y, Tar MT, Fu S, Melman A, Davies KP. Diabetes attenuates urothelial modulation of detrusor contractility and spontaneous activity. Int J Urol. 2014;21(10):1059–64.PubMedCrossRef

29.

Kirschner-Hermanns R, Daneshgari F, Vahabi B, Birder L, Oelke M, Chacko S. Does diabetes mellitus-induced bladder remodeling affect lower urinary tract function? ICI-RS 2011. Neurourol Urodyn. 2012;31(3):359–64.PubMedCrossRef

30.

Xiao N, Wang Z, Huang Y, Daneshgari F, Liu G. Roles of polyuria and hyperglycemia in bladder dysfunction in diabetes. J Urol. 2013;189(3):1130–6.PubMedCentralPubMedCrossRef

31.

Christ GJ, Hsieh Y, Zhao W, Schenk G, Venkateswarlu K, Wang HZ, et al. Effects of streptozotocin-induced diabetes on bladder and erectile (dys)function in the same rat in vivo. BJU Int. 2006;97(5):1076–82.PubMedCrossRef

32.

Mayo ME, Chetner MP. Lower urinary tract dysfunction in multiple sclerosis. Urology. 1992;39(1):67–70.PubMedCrossRef

33.

Betts CD, D'Mellow MT, Fowler CJ. Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1993;56(3):245–50.PubMedCentralPubMedCrossRef

34.

Gallien P, Robineau S, Nicolas B, Le Bot MP, Brissot R, Verin M. Vesicourethral dysfunction and urodynamic findings in multiple sclerosis: a study of 149 cases. Arch Phys Med Rehabil. 1998;79(3):255–7.PubMedCrossRef

35.

Litwiller SE, Frohman EM, Zimmern PE. Multiple sclerosis and the urologist. J Urol. 1999;161(3):743–57.PubMedCrossRef

36.

Uchiyama T, Sakakibara R, Yamamoto T, Ito T, Yamaguchi C, Awa Y, et al. Urinary dysfunction in early and untreated Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2011;82(12):1382–6.PubMedCrossRef

37.

Kim M, Jung JH, Park J, Son H, Jeong SJ, Oh SJ, et al. Seoul National University Experts Of Urodynamics Leading Study G: Impaired detrusor contractility is the pathognomonic urodynamic finding of multiple system atrophy compared to idiopathic Parkinson’s disease. Parkinsonism Relat Disord. 2015;21(3):205–10.PubMedCrossRef

38.

Naphade PU, Verma R, Garg RK, Singh M, Malhotra HS, Shankwar SN. Prevalence of bladder dysfunction, urodynamic findings, and their correlation with outcome in Guillain-Barre syndrome. NeurourolUrodyn. 2012;31(7):1135–40.

39.

Burney TL, Senapati M, Desai S, Choudhary ST, Badlani GH. Acute cerebrovascular accident and lower urinary tract dysfunction: a prospective correlation of the site of brain injury with urodynamic findings. J Urol. 1996;156(5):1748–50.PubMedCrossRef

40.

Pizzi A, Falsini C, Martini M, Rossetti MA, Verdesca S, Tosto A. Urinary incontinence after ischemic stroke: clinical and urodynamic studies. NeurourolUrodyn. 2014;33(4):420–5.

41.

Lange MM, van de Velde CJ. Urinary and sexual dysfunction after rectal cancer treatment. Nat Rev Urol. 2011;8(1):51–7.PubMedCrossRef

42.

Brooks RA, Wright JD, Powell MA, Rader JS, Gao F, Mutch DG, et al. Long-term assessment of bladder and bowel dysfunction after radical hysterectomy. Gynecol Oncol. 2009;114(1):75–9.PubMedCrossRef

43.

Chung DE, Dillon B, Kurta J, Maschino A, Cronin A, Sandhu JS: Detrusor underactivity is prevalent after radical prostatectomy: a urodynamic study including risk factors. Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2012:1–5.

44.

Osman NI, Chapple CR. Contemporary concepts in the aetiopathogenesis of detrusor underactivity. Nat Rev Urol. 2014;11(11):639–48.PubMedCrossRef

45.

Saito M, Yokoi K, Ohmura M, Kondo A. Effects of partial outflow obstruction on bladder contractility and blood flow to the detrusor: comparison between mild and severe obstruction. Urol Int. 1997;59(4):226–30.PubMedCrossRef

46.

Levin RM, Longhurst PA, Barasha B, McGuire EJ, Elbadawi A, Wein AJ. Studies on experimental bladder outlet obstruction in the cat: long-term functional effects. J Urol. 1992;148(3):939–43.PubMed

47.

Al-Hayek S, Thomas A, Abrams P. Natural history of detrusor contractility—minimum ten-year urodynamic follow-up in men with bladder outlet obstruction and those with detrusor. Scand J Urol Nephrol Suppl. 2004;215:101–8.PubMedCrossRef

48.

Chancellor MB. The overactive bladder progression to underactive bladder hypothesis. Int Urol Nephrol. 2014;46 Suppl 1:S23–27.PubMedCrossRef

49.

Gammie A, Kaper M, Dorrepaal C, Kos T, Abrams P: Signs and symptoms of detrusor underactivity: an analysis of clinical presentation and urodynamic tests from a large group of patients undergoing pressure flow studies. European urology 2015.

50.

Schafer W. Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple. World J Urol. 1995;13(1):47–58.PubMedCrossRef

51.

Abrams P. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int. 1999;84(1):14–5.PubMedCrossRef

52.

van Koeveringe GA, Vahabi B, Andersson KE, Kirschner-Herrmans R, Oelke M. Detrusor underactivity: a plea for new approaches to a common bladder dysfunction. NeurourolUrodyn. 2011;30(5):723–8.

53.

Valentini FA, Besson GR, Nelson PP, Zimmern PE. Clinically relevant modeling of urodynamics function: the VBN model. NeurourolUrodyn. 2014;33(3):361–6.

54.

Barendrecht MM, Oelke M, Laguna MP, Michel MC. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU Int. 2007;99(4):749–52.PubMedCrossRef

55.

Riedl CR, Stephen RL, Daha LK, Knoll M, Plas E, Pfluger H. Electromotive administration of intravesical bethanechol and the clinical impact on acontractile detrusor management: introduction of a new test. J Urol. 2000;164(6):2108–11.PubMedCrossRef

56.

Sugaya K, Kadekawa K, Onaga T, Ashitomi K, Mukouyama H, Nakasone K, et al. Effect of distigmine at 5 mg daily in patients with detrusor underactivity. Nihon Hinyokika Gakkai zasshi The Japanese J Urology. 2014;105(1):10–6.

57.

Yamanishi T, Yasuda K, Kamai T, Tsujii T, Sakakibara R, Uchiyama T, et al. Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int J Urol. 2004;11(2):88–96.PubMedCrossRef

58.

Chang SJ, Chiang IN, Yu HJ. The effectiveness of tamsulosin in treating women with voiding difficulty. Int J Urol. 2008;15(11):981–5.PubMedCrossRef

59.

Wilt TJ, Mac Donald R, Rutks I: Tamsulosin for benign prostatic hyperplasia. The Cochrane database of systematic reviews 2003(1):CD002081.

60.

Prieto J, Murphy CL, Moore KN, Fader M: Intermittent catheterisation for long-term bladder management. The Cochrane database of systematic reviews 2014, 9:Cd006008.

61.

Jonas U, Fowler CJ, Chancellor MB, Elhilali MM, Fall M, Gajewski JB, et al. Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol. 2001;165(1):15–9.PubMedCrossRef

62.

Masumori N, Furuya R, Tanaka Y, Furuya S, Ogura H, Tsukamoto T. The 12-year symptomatic outcome of transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction compared to the urodynamic findings before surgery. BJU Int. 2010;105(10):1429–33.PubMedCrossRef

63.

Seki N, Kai N, Seguchi H, Takei M, Yamaguchi A, Naito S. Predictives regarding outcome after transurethral resection for prostatic adenoma associated with detrusor underactivity. Urology. 2006;67(2):306–10.PubMedCrossRef

64.

Thorner DA, Blaivas JG, Tsui JF, Kashan MY, Weinberger JM, Weiss JP. Outcomes of reduction cystoplasty in men with impaired detrusor contractility. Urology. 2014;83(4):882–6.PubMedCrossRef

65.

Stenzl A, Ninkovic M, Kolle D, Knapp R, Anderl H, Bartsch G. Restoration of voluntary emptying of the bladder by transplantation of innervated free skeletal muscle. Lancet. 1998;351(9114):1483–5.PubMedCrossRef

66.

Ninkovic M, Stenzl A, Schwabegger A, Bartsch G, Prosser R, Ninkovic M. Free neurovascular transfer of latissimus dorsi muscle for the treatment of bladder acontractility: II. Clinical results. J Urol. 2003;169(4):1379–83.PubMedCrossRef

67.

Andersson KE, Wein AJ. Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence. Pharmacol Rev. 2004;56(4):581–631.PubMedCrossRef

68.

Andersson KE. Detrusor underactivity/underactive bladder: new research initiatives needed. J Urol. 2010;184(5):1829–30.PubMedCrossRef

69.

Chancellor MB, Kaufman J. Case for pharmacotherapy development for underactive bladder. Urology. 2008;72(5):966–7.PubMedCrossRef

70.

Levanovich PE, Diokno A, Hasenau DL, Lajiness M, Pruchnic R, Chancellor MB. Intradetrusor injection of adult muscle-derived cells for the treatment of underactive bladder: pilot study. Int Urol Nephrol. 2015;47(3):465–7.PubMedCrossRef

71.

Chancellor DD. Advancing underactive bladder research through public-private collaboration. Int Urol Nephrol. 2014;46 Suppl 1:S45–46.PubMedCrossRef

72.

Vereecke A, Chancellor M. Building momentum toward underactive bladder research and education. Int Urol Nephrol. 2015.

73.

Rodrigues P, Hering F, Meller A, D'Imperio M. Outline of 3,830 male patients referred to urodynamic evaluation for lower urinary tract symptoms: how common is infravesical outlet obstruction? Urol Int. 2009;83(4):404–9.PubMedCrossRef

74.

Pfisterer MH, Griffiths DJ, Schaefer W, Resnick NM. The effect of age on lower urinary tract function: a study in women. J Am Geriatr Soc. 2006;54(3):405–12.PubMedCrossRef

75.

Valentini FA, Robain G, Marti BG. Urodynamics in women from menopause to oldest age: what motive? What diagnosis? Int Braz J Urol. 2011;37(1):100–7.PubMedCrossRef

76.

Griffiths D, Tadic SD, Schaefer W, Resnick NM. Cerebral control of the bladder in normal and urge-incontinent women. Neuroimage. 2007;37(1):1–7.PubMedCentralPubMedCrossRef

77.

Madersbacher S, Pycha A, Schatzl G, Mian C, Klingler CH, Marberger M. The aging lower urinary tract: a comparative urodynamic study of men and women. Urology. 1998;51(2):206–12.PubMedCrossRef

78.

Madersbacher S, Klingler HC, Schatzl G, Stulnig T, Schmidbauer CP, Marberger M. Age related urodynamic changes in patients with benign prostatic hyperplasia. J Urol. 1996;156(5):1662–7.PubMedCrossRef

Title: Underactive Bladder
Authors: Himanshu Aggarwal
Philippe E. Zimmern
Publication date: 01-03-2016
Publisher: Springer US
Published in: Current Urology Reports / Issue 3/2016
Print ISSN: 1527-2737
Electronic ISSN: 1534-6285
DOI: https://doi.org/10.1007/s11934-016-0582-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Underactive Bladder

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2016

Prostate Cancer Imaging with Novel PET Tracers

Contemporary Status of Percutaneous Ablation for the Small Renal Mass

Evolving Guidance on Ureteric Calculi Management in the Acute Setting

Grading of Prostate Cancer: Past, Present, and Future

The Utility of Molecular Imaging in Prostate Cancer

Rectourethral Fistula Management